Export 2708 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
M. D. Bellin, Barton, F. B., Heitman, A., Harmon, J., Balamurugan, A. N., Kandaswamy, R., Sutherland, D. E., Alejandro, R., and Hering, B. J., Potent Induction Immunotherapy Promotes Long-Term Insulin Independence After Islet Transplantation in Type 1 Diabetes, Am J Transplant, vol. 12, pp. 1576-1583, 2012.
M. D. Bellin, Barton, F. B., Heitman, A., Harmon, J. V., Kandaswamy, R., Balamurugan, A. N., Sutherland, D. E. R., Alejandro, R., and Hering, B. J., Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes., Am J Transplant, vol. 12, no. 6, pp. 1576-83, 2012.
R. B. Belshe, Newman, F. K., Wilkins, K., Graham, I. L., Babusis, E., Ewell, M., and Frey, S. E., Comparative Immunogenicity of Trivalent Influenza Vaccine Administered by Intradermal or Intramuscular Route in Healthy Adults, Vaccine, vol. 25, pp. 6755-6763, 2007.
R. Belshe, Bolognesi, D., Clements, M., Corey, L., Fast, P., Graham, B., Keefer, M., Mestecky, J., Mulligan, M., Stablein, D., and Group, A. I. D. S. Vaccine Cl, Progress in HIV-1 Vaccine Development. Washington DC, 1995.
R. B. Belshe, Newman, F. K., Wilkins, K., Graham, I. L., Babusis, E., Ewell, M., and Frey, S. E., Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults., Vaccine, vol. 25, no. 37-38, pp. 6755-63, 2007.
R. B. Belshe, Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P., Dolor, R. J., Woods, C. W., Walter, E. B., Chen, W. H., Turley, C., Edwards, K. M., Creech, C. B., Hill, H., and Bellamy, A. R., Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine with MF59 Adjuvant: A Randomized Clinical Trial, JAMA, vol. 312, pp. 1420-1428, 2014.
R. B. Belshe, Leone, P. A., Bernstein, D. I., Wald, A., Levin, M. J., Stapleton, J. T., Gorfinkel, I., Morrow, R. L. Ashley, Ewell, M. G., Stokes-Riner, A., Dubin, G., Heineman, T. C., Schulte, J. M., and Deal, C. D., Efficacy results of a trial of a herpes simplex vaccine., N Engl J Med, vol. 366, no. 1, pp. 34-43, 2012.
R. B. Belshe, Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P., Dolor, R. J., Woods, C. W., Walter, E. B., Chen, W. H., Turley, C., Edwards, K. M., C Creech, B., Hill, H., and Bellamy, A. R., Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial., JAMA, vol. 312, no. 14, pp. 1420-8, 2014.
R. B. Belshe, Newman, F. K., Frey, S. E., Couch, R. B., Treanor, J. J., Tacket, C. O., and Yan, L., Dose-dependent neutralizing-antibody responses to vaccinia., J Infect Dis, vol. 189, no. 3, pp. 493-7, 2004.
R. B. Belshe, Stevens, C., Gorse, G. J., Buchbinder, S., Weinhold, K., Sheppard, H., Stablein, D., Self, S., McNamara, J., Frey, S., Flores, J., Excler, J. L., Klein, M., Habib, R. E., Duliege, A. M., Harro, C., Corey, L., Keefer, M., Mulligan, M., Wright, P., Celum, C., Judson, F., and , Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers, J Infec Dis, vol. 183, pp. 1343-52, 2001.
R. B. Belshe, Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., Iacuzio, D., and Wolff, M., The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children., N Engl J Med, vol. 338, no. 20, pp. 1405-12, 1998.
R. B. Belshe, Heineman, T. C., Bernstein, D. I., Bellamy, A. R., Ewell, M., van der Most, R., and Deal, C. D., Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women, J Infect Dis, vol. 209, pp. 828-836, 2014.
R. B. Belshe, Newman, F. K., Frey, S. E., Couch, R. B., Treanor, J. J., Tacket, C. O., and Yan, L., Dose-dependent neutralizing-antibody responses to vaccinia, Journal of Infectious Diseases, vol. 189, pp. 493-7, 2004.
B. R. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Cho, I., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine, J Infec Dis, vol. 181, pp. 11133-7, 2000.
R. B. Belshe, Gruber, W. C., Mendelman, P. M., Cho, I., Reisinger, K., Block, S. L., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., King, J., Kotloff, K., Bernstein, D. I., Hayden, F. G., Zangwill, K., Yan, L., and Wolff, M., Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine., J Pediatr, vol. 136, no. 2, pp. 168-75, 2000.
R. B. Belshe, Gruber, W., Mendelman, P. M., Cho, I., Reisinger, K., Block, S., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., King, J., Kotloff, K., Bernstein, D. I., Hayden, F. G., Zangwill, K., Yan, L., and Wolff, M. C., Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine, J Pediatric, vol. 136, pp. 168-175, 2000.
R. B. Belshe, Frey, S. E., Graham, I., Mulligan, M. J., Edupuganti, S., Jackson, L. A., Wald, A., Poland, G., Jacobson, R., Keyserling, H. L., Spearman, P., Hill, H., and Wolff, M., Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant., J Infect Dis, vol. 203, no. 5, pp. 666-73, 2011.
R. B. Belshe, Stevens, C., Gorse, G. J., Buchbinder, S., Weinhold, K., Sheppard, H., Stablein, D., Self, S., McNamara, J., Frey, S., Flores, J., Excler, J. L., Klein, M., Habib, R. E., Duliege, A. M., Harro, C., Corey, L., Keefer, M., Mulligan, M., Wright, P., Celum, C., Judson, F., Mayer, K., McKirnan, D., Marmor, M., and Woody, G., Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers., J Infect Dis, vol. 183, no. 9, pp. 1343-52, 2001.
R. B. Belshe, Blevins, T. P., Yu, Y., Nethington, A. E., Bellamy, A., Bryant, C., and Morrison, L. A., Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated Women, J Infect Dis, vol. 227, no. 4, pp. 522-527, 2023.
R. B. Belshe, Mendelman, P. M., Treanor, J., King, J., Gruber, W., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., Iacuzio, I., and Wolff, M. C., The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children, N Engl J Med, vol. 338, pp. 1405-12, 1998.
R. B. Belshe, Heineman, T. C., Bernstein, D. I., Bellamy, A. R., Ewell, M., van der Most, R., and Deal, C. D., Correlate of immune protection against HSV-1 genital disease in vaccinated women., J Infect Dis, vol. 209, no. 6, pp. 828-36, 2014.
R. B. Belshe, Leone, P. A., Bernstein, D. I., Wald, A., Levin, M., Stapleton, J. T., Gorfinkel, I., Morrow, R. L., Ewell, M. G., Stokes-Riner, A., Dubin, G., Heineman, T. C., Schulte, J. M., Deal, C. D., and Women, H. Trial for, Efficacy Results of A Trial of A Herpes Simplex Vaccine, N Engl J Med, vol. 366, pp. 34-43, 2012.
R. B. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine., J Infect Dis, vol. 181, no. 3, pp. 1133-7, 2000.
M. R. Benfield, Stablein, D., and Tejani, A., Trends in immunosuppressive therapy: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)., Pediatr Transplant, vol. 3, no. 1, pp. 27-32, 1999.
M. Benfield, Herrin, J., Feld, L., Rose, S., Stablein, D., and Tejani, A., Safety of kidney biopsy in pediatric transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), transplantation, vol. 67, pp. 544-47, 1999.